Examining the Effectiveness of the myPlan App to Prevent Dating Violence With Adolescents
Launched by JOHNS HOPKINS UNIVERSITY · Sep 21, 2020
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 15-17 years old
- • Lives in the United States
- • Reports current or past 6 months physical violence, sexual violence, emotional abuse, verbal abuse, or staking (including cyberstalking or electronic aggression) by a dating/casual/intimate/ex-intimate partner
- • Speaks/reads English
- • Has access to a safe device (e.g., smartphone, tablet, or computer) with internet access and comfortable downloading an app or using the internet
- • Has a safe contact phone number or email address
- Exclusion Criteria:
- • Younger than 15 years of age
- • Older than 17 years of age
- • Does not report current or past 6 months abuse from a dating/casual/intimate/ex- intimate partner
- • Does not speak/read English
- • Does not have access to a safe device (e.g., smartphone, tablet, or computer) with internet access
- • Does not have a safe contact phone number or email address
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Columbia, Missouri, United States
Patients applied
Trial Officials
Nancy E Glass, PhD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials